Could Corpay (CPAY) Be 47% Below Fair Value On Earnings Estimate Upgrades?

Corpay, Inc.

Corpay, Inc.

CPAY

0.00

Corpay (CPAY) has drawn fresh attention after upward revisions to full-year earnings estimates coincided with improving industry rankings and supportive analyst sentiment, increasing the focus on how its financial profile aligns with the recent share price move.

At a share price of $344.26, Corpay has seen a 17.41% 90 day share price return and a 40.01% three year total shareholder return. This suggests that recent momentum has added to an already solid longer term record as investors reassess its growth profile and risk.

If you are looking beyond Corpay for other potential ideas in high growth areas of the market, this is a good time to see what stands out in 61 profitable AI stocks that aren't just burning cash

With Corpay trading at $344.26 and sitting about 14.8% below the average analyst price target, the key question now is whether the current valuation still leaves potential upside on the table or if the market is already factoring in future growth.

Preferred P/E of 19.2x: Is it justified?

For Corpay, the most visible yardstick right now is the P/E ratio of 19.2x, which sits against a share price of $344.26 and points to a richer valuation than several benchmarks.

The P/E ratio compares the current share price with earnings per share and is a quick way to see how much investors are paying for each dollar of profit. For a payments focused diversified financial company like Corpay, it effectively wraps together expectations on earnings quality, growth and risk into a single number.

On one hand, Corpay is described as trading at 47.4% below an internal fair value estimate of future cash flows, and its earnings have been growing, with 15.2% earnings growth over the past year and 6.5% per year over the past five years. On the other hand, that 19.2x P/E is higher than both the estimated fair P/E of 18.7x and the peer averages, which suggests the market is already placing a premium on its profit profile compared with many diversified financial peers.

The gap versus other reference points is clear. Corpay’s P/E of 19.2x is higher than the US diversified financial industry average of 15x and the peer average of 13x, so investors are paying significantly more per dollar of earnings than they would for many similar stocks. Compared with the estimated fair P/E of 18.7x, the current multiple is also slightly above where regression based analysis suggests it could settle if pricing moved closer to that fair ratio level.

Result: Price-to-Earnings of 19.2x (OVERVALUED)

However, there are still clear risks to watch, including the possibility that Corpay’s premium P/E could be hard to justify if revenue or net income growth slows.

Another view on Corpay's value

While Corpay screens as expensive on its 19.2x P/E, the SWS DCF model points the other way, with an estimated future cash flow value of $654.50 per share versus the current $344.26 price, implying the stock trades at a discount rather than a premium.

That gap between an earnings based premium and a cash flow based discount raises a simple question for investors: which signal matters more for you right now, the higher multiple or the DCF upside implied by future cash generation?

CPAY Discounted Cash Flow as at Jun 2026
CPAY Discounted Cash Flow as at Jun 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Corpay for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Corpay showing both premium valuation signals and a discounted DCF view, sentiment is clearly mixed. It makes sense to check the data yourself and move quickly if it shifts your stance. To see both the upside arguments and what could go wrong laid out side by side, review the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Corpay?

If Corpay has sharpened your focus on quality and valuation, do not stop here. Use the Simply Wall Street Screener to surface other opportunities before the crowd.

  • Spot potential value candidates early by scanning a curated set of 44 high quality undervalued stocks that combine attractive pricing with solid underlying business metrics.
  • Strengthen the defensive side of your portfolio by checking 69 resilient stocks with low risk scores built around companies with more resilient risk profiles.
  • Hunt for lesser known opportunities by reviewing a screener containing 18 high quality undiscovered gems that could otherwise sit under the radar.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.